Clinical trial
Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian…
NCT00322881 · Dana-Farber Cancer Institute, Other · Terminated
Key facts
| NCT number | NCT00322881 |
|---|---|
| Title | Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer |
| Official title | A Phase II Study of Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital Massachusetts General Hospital |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer, Mixed Tumor, Mesodermal |
| Intervention type | Drug |
| Interventions | Paclitaxel, Carboplatin |
| Enrollment | 12 |
| Start date | Apr 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2010 |
| First posted | May 8, 2006 |
| Last update posted | Sep 10, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: